Pure Global
NCT06358755

Combination Effect of Optical Defocus and Low Dose Atropine in Myopia Control

Combination Effect of Optical Defocus and Low Dose Atropine in Myopia Control - a Randomized Clinical Trial
The Hong Kong Polytechnic University·Phase 2·ClinicalTrials.gov·device·Device trialNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Myopia
Drug/Device/Intervention
Defocus Incorporated Multiple Segments lenses
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
The Hong Kong Polytechnic University
Location
Hong Kong, China
Timeline & enrollment
Phase
Phase 2
Start date
May 01, 2024
End date
Oct 31, 2026
Enrollment
112 participants
Primary outcome

Changes in cycloplegic refraction,Changes in axial length

Summary

The purpose of the study is to investigate the combination effect of optical defocus and low
 dose atropine on myopia control in schoolchildren.

ICD-10 classifications
MyopiaDegenerative myopiaAmblyopia ex anopsiaOcular myiasisMyiasis
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06358755
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06358755 through Pure Global AI's free database. This Phase 2 trial is sponsored by The Hong Kong Polytechnic University and is currently Not yet recruiting. The study focuses on Myopia. Target enrollment is 112 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.